Asset Details
Do you wish to reserve the book?
Radioiodine Ablation in Low-Risk Thyroid Cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Radioiodine Ablation in Low-Risk Thyroid Cancer
Do you wish to request the book?
Radioiodine Ablation in Low-Risk Thyroid Cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Radioiodine Ablation in Low-Risk Thyroid Cancer
2012
Overview
To the Editor:
The article by Schlumberger et al. (May 3 issue)
1
accurately identifies the lack of evidence for any benefit of radioiodine ablation in patients with low-risk thyroid cancer after complete surgical resection but goes on to compare two radioiodine doses (1.1 GBq and 3.7 GBq) in a randomized fashion. Logically, it would seem to be necessary to establish the benefit of a therapy before investigating its ideal dose. Unfortunately, a systematic review of the literature
2
has shown no definitive benefit for radioiodine ablation in decreasing rates of recurrence or death in patients with low-risk thyroid cancer. Thus, the . . .
Publisher
Massachusetts Medical Society
